SkyWest Inc (SKYW) Stock Price Today
Aura AI Summary
Key Stats
- $3.97BMarket Cap
- -Volume
- TechnologySector
- $123.7252W High
- $78.4052W Low
- -Typical Hold Time
- $5.82BEnterprise Value
- -Div Yield
- -Trading Activity
Track SkyWest Inc (SKYW) stock price today on Pluang, updated in real time with live charts and market data. Over the past 52 weeks, SkyWest Inc has traded between a low of $78.4 and a high of $123.72, highlighting its annual price range. Buy and sell SkyWest Inc shares on Pluang with fractional shares and real-time market data — safe and OJK-regulated.
About SkyWest Inc
SkyWest, Inc. is a major North American regional airline company, operating primarily through its subsidiary, SkyWest Airlines. The company provides regional airline service to various large airlines under contract, including United Airlines (as United Express), Delta Air Lines (as Delta Connection), American Airlines (as American Eagle), and Alaska Airlines (as Alaska SkyWest). SKYW's primary business is providing essential flight services, connecting smaller cities to major airline hubs across the United States.
Most Recent News
Renewed U.S.-Iran tensions push oil prices up, impacting key economic sectors and confirming AI investment confidence.
Renewed hostilities between the U.S. and Iran, including attacks on commercial vessels in the Strait of Hormuz and reinstated U.S. sanctions on Iran, caused crude oil prices to rise sharply. This increase pressured economically sensitive sectors such...

Alamar Biosciences' NULISA platform featured in 140+ studies at AAIC 2026, advancing blood-based Alzheimer's biomarker detection.
Alamar Biosciences announced that its NULISA platform was prominently featured in over 140 scientific presentations at the 2026 Alzheimer's Association International Conference (AAIC) in London, highlighting its growing adoption in Alzheimer's resear...

Alamar Biosciences showcases over 140 presentations on blood-based Alzheimer's biomarkers at AAIC 2026.
Alamar Biosciences presented extensive data from its NULISA platform at the AAIC 2026 conference, highlighting advances in blood-based biomarkers for Alzheimer's detection and staging. The company emphasized new findings on eMTBR-Tau and BD-pTau217, ...
